National Institute of Mental Health; Notice of Meeting, 32559-32560 [2014-13026]

Download as PDF Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices accessible by webcast and conference call. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute (NCI) Ad hoc Clinical Trials Strategic Planning Subcommittee of the NCI Clinical Trials and Translational Research Advisory Committee (CTAC), July 8, 2014, 2:00 p.m. to July 8, 2014, 3:00 p.m., National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, 6West CCCT Huddle Room, Rockville, MD, 20850 which was published in the Federal Register on May 8, 2014, 79 FR 26441. This notice is being amended to change the meeting type to a webinar. The meeting will be open to the public. Pertinent information related to the webinar is as follows: Go to: https://cbiit.webex.com/cbiit/ j.php?MTID=m3d3b0b1886a6e7b32fb f568ae44f6915 Meeting Password: ctac. Meeting Number: 735 128 827. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: Open Meeting. Date: July 8, 2014. Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end time. Agenda: To discuss committee business, updates and issues related to ASD research and services activities. Place: National Institute of Mental Health, The Neuroscience Center, 6001 Executive Boulevard, Conference Rooms C and D, Rockville, Maryland 20852. Webcast Live: https://videocast.nih.gov/. National Institute of Mental Health; Notice of Meeting Conference Call Access: Dial: 888–946–7606, Access code: 9653752. Cost: The meeting is free and open to the public. Registration: Pre-registration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis. To register, please visit: www.iacc.hhs.gov. Deadlines: Notification of intent to present oral comments: Monday, June 30, 2014 by 5:00 p.m. ET. Submission of written/ electronic statement for oral comments: Tuesday, July 1, 2014 by 5:00 p.m. ET. Submission of written comments: Tuesday, July 1, 2014 by 5:00 p.m. ET. Please note: The NIMH Office of Autism Research Coordination (OARC) anticipates that written public comments received by 5:00 p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee prior to the July 8th meeting for the Committee’s consideration. Any written comments received after the 5:00 p.m. EST, July 1, 2014 deadline through July 7, 2014 will be provided to the Committee either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. For IACC Public Comment guidelines, please see: https://iacc.hhs.gov/publiccomment/index.shtml. Access: White Flint Metro Station (Red Line). Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Room 6182A, Bethesda, MD 20892–9669, Phone: 301–443–6040, Email: IACCPublicInquiries@mail.nih.gov. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Autism Coordinating Committee (IACC or Committee) meeting. The purpose of the IACC meeting is to discuss committee business, agency updates and issues related to autism spectrum disorder (ASD) research and services activities. The meeting will be open to the public and will be Public Comments Any member of the public interested in presenting oral comments to the Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Monday, June 30, 2014, with their request to present oral comments at the meeting. Interested individuals and representatives of organizations must submit a written/electronic copy of the oral presentation/statement including a brief description of the organization Audio Connection 1. Provide your number when you join the meeting to receive a call back. Alternatively, you can call the following number: Dial In Number: 1–240–276– 6338. 2. Follow the instructions that you hear on the phone. Your Cisco Unified MeetingPlace meeting ID: 730 501 868. Dated: May 31, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–13025 Filed 6–4–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES rmajette on DSK2TPTVN1PROD with NOTICES National Institutes of Health VerDate Mar<15>2010 14:59 Jun 04, 2014 Jkt 232001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 32559 represented by 5:00 p.m. ET on Tuesday, July 1, 2014. Statements submitted will become a part of the public record. Only one representative of an organization will be allowed to present oral comments and presentations will be limited to three to five minutes per speaker, depending on the number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received, along with the required submission of the written/electronic statement by the specified deadline. In addition, any interested person may submit written comments to the IACC prior to the meeting by sending the comments to the Contact Person listed on this notice by 5:00 p.m. ET on Tuesday, July 1, 2014. The comments should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. NIMH anticipates written public comments received by 5:00 p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee prior to the meeting for the Committee’s consideration. Any written comments received after the 5:00 p.m. EST, July 1, 2014 deadline through July 7, 2014 will be provided to the Committee either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. All written public comments and oral public comment statements received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. In the 2009 IACC Strategic Plan, the IACC listed the ‘‘Spirit of Collaboration’’ as one of its core values, stating that, ‘‘We will treat others with respect, listen to diverse views with open minds, discuss submitted public comments, and foster discussions where participants can comfortably offer opposing opinions.’’ In keeping with this core value, the IACC and the NIMH Office of Autism Research Coordination (OARC) ask that members of the public who provide public comments or participate in meetings of the IACC also seek to treat others with respect and consideration in their communications and actions, even when discussing issues of genuine concern or disagreement. Remote Access The meeting will be open to the public through a conference call phone E:\FR\FM\05JNN1.SGM 05JNN1 32560 Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices number and webcast live on the Internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the webcast or conference call, please send an email to helpdeskiacc@ gmail.com or by phone at 415–652– 8023. Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least 5 days prior to the meeting. Security In the interest of security, visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit upon entrance to the Neuroscience Center. Also as a part of security procedures, attendees should be prepared to present a photo ID at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are pre-registered. Meeting schedule subject to change. Information about the IACC is available on the Web site: https:// www.iacc.hhs.gov. Dated: May 30, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–13026 Filed 6–4–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rmajette on DSK2TPTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning VerDate Mar<15>2010 14:59 Jun 04, 2014 Jkt 232001 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Gene and Drug Delivery Systems Study Section. Date: June 12–13, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202. Contact Person: Amy L Rubinstein, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5152, MSC 7844, Bethesda, MD 20892, 301–408– 9754, rubinsteinal@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Molecular Targets for Cancer Intervention. Date: June 30, 2014. Time: 7:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Careen K Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301)435– 3504, tothct@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pain and Chemosensory Neuroscience. Date: July 1–2, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Bishop, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–HG– 14–001: BD2K–LINCS-Perturbation Data Coordination and Integration Center. Date: July 2, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD. Contact Person: James J Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301–806–8065, lijames@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Review Group; Neurogenesis and Cell Fate Study Section. Date: July 2, 2014. Time: 9:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington Embassy Row, 2015 Massachusetts Ave. NW., Washington, DC 20036. Contact Person: Joanne T Fujii, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, (301) 435– 1178, fujiij@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 30, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–13027 Filed 6–4–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: 2015 National Survey on Drug Use and Health (OMB No. 0930–0110)— Revision The National Survey on Drug Use and Health (NSDUH) is a survey of the U.S. civilian, non-institutionalized population aged 12 years old or older. The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, the Office of National Drug Control Policy (ONDCP), Federal government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources. In order to continue producing current data, SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ) must periodically update aspects of the NSDUH to reflect the E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 79, Number 108 (Thursday, June 5, 2014)]
[Notices]
[Pages 32559-32560]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13026]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of an Interagency 
Autism Coordinating Committee (IACC or Committee) meeting.
    The purpose of the IACC meeting is to discuss committee business, 
agency updates and issues related to autism spectrum disorder (ASD) 
research and services activities. The meeting will be open to the 
public and will be accessible by webcast and conference call.

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Type of meeting: Open Meeting.
    Date: July 8, 2014.
    Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end 
time.
    Agenda: To discuss committee business, updates and issues 
related to ASD research and services activities.
    Place: National Institute of Mental Health, The Neuroscience 
Center, 6001 Executive Boulevard, Conference Rooms C and D, 
Rockville, Maryland 20852.
    Webcast Live: https://videocast.nih.gov/.

Conference Call

    Access: Dial: 888-946-7606, Access code: 9653752.
    Cost: The meeting is free and open to the public.
    Registration: Pre-registration is recommended to expedite check-
in. Seating in the meeting room is limited to room capacity and on a 
first come, first served basis. To register, please visit: 
www.iacc.hhs.gov.
    Deadlines: Notification of intent to present oral comments: 
Monday, June 30, 2014 by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments: Tuesday, July 1, 2014 by 
5:00 p.m. ET. Submission of written comments: Tuesday, July 1, 2014 
by 5:00 p.m. ET.
    Please note: The NIMH Office of Autism Research Coordination 
(OARC) anticipates that written public comments received by 5:00 
p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee 
prior to the July 8th meeting for the Committee's consideration. Any 
written comments received after the 5:00 p.m. EST, July 1, 2014 
deadline through July 7, 2014 will be provided to the Committee 
either before or after the meeting, depending on the volume of 
comments received and the time required to process them in 
accordance with privacy regulations and other applicable Federal 
policies.
    For IACC Public Comment guidelines, please see: https://iacc.hhs.gov/public-comment/index.shtml.
    Access: White Flint Metro Station (Red Line).
    Contact Person: Ms. Lina Perez, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone: 
301-443-6040, Email: IACCPublicInquiries@mail.nih.gov.

Public Comments

    Any member of the public interested in presenting oral comments to 
the Committee must notify the Contact Person listed on this notice by 
5:00 p.m. ET on Monday, June 30, 2014, with their request to present 
oral comments at the meeting. Interested individuals and 
representatives of organizations must submit a written/electronic copy 
of the oral presentation/statement including a brief description of the 
organization represented by 5:00 p.m. ET on Tuesday, July 1, 2014. 
Statements submitted will become a part of the public record. Only one 
representative of an organization will be allowed to present oral 
comments and presentations will be limited to three to five minutes per 
speaker, depending on the number of speakers to be accommodated within 
the allotted time. Speakers will be assigned a time to speak in the 
order of the date and time when their request to speak is received, 
along with the required submission of the written/electronic statement 
by the specified deadline.
    In addition, any interested person may submit written comments to 
the IACC prior to the meeting by sending the comments to the Contact 
Person listed on this notice by 5:00 p.m. ET on Tuesday, July 1, 2014. 
The comments should include the name, address, telephone number and 
when applicable, the business or professional affiliation of the 
interested person. NIMH anticipates written public comments received by 
5:00 p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee 
prior to the meeting for the Committee's consideration. Any written 
comments received after the 5:00 p.m. EST, July 1, 2014 deadline 
through July 7, 2014 will be provided to the Committee either before or 
after the meeting, depending on the volume of comments received and the 
time required to process them in accordance with privacy regulations 
and other applicable Federal policies. All written public comments and 
oral public comment statements received by the deadlines for both oral 
and written public comments will be provided to the IACC for their 
consideration and will become part of the public record.
    In the 2009 IACC Strategic Plan, the IACC listed the ``Spirit of 
Collaboration'' as one of its core values, stating that, ``We will 
treat others with respect, listen to diverse views with open minds, 
discuss submitted public comments, and foster discussions where 
participants can comfortably offer opposing opinions.'' In keeping with 
this core value, the IACC and the NIMH Office of Autism Research 
Coordination (OARC) ask that members of the public who provide public 
comments or participate in meetings of the IACC also seek to treat 
others with respect and consideration in their communications and 
actions, even when discussing issues of genuine concern or 
disagreement.

Remote Access

    The meeting will be open to the public through a conference call 
phone

[[Page 32560]]

number and webcast live on the Internet. Members of the public who 
participate using the conference call phone number will be able to 
listen to the meeting but will not be heard. If you experience any 
technical problems with the webcast or conference call, please send an 
email to helpdeskiacc@gmail.com or by phone at 415-652-8023.
    Individuals who participate in person or by using these electronic 
services and who need special assistance, such as captioning of the 
conference call or other reasonable accommodations, should submit a 
request to the Contact Person listed on this notice at least 5 days 
prior to the meeting.

Security

    In the interest of security, visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their visit 
upon entrance to the Neuroscience Center. Also as a part of security 
procedures, attendees should be prepared to present a photo ID at the 
meeting registration desk during the check-in process. Pre-registration 
is recommended. Seating will be limited to the room capacity and seats 
will be on a first come, first served basis, with expedited check-in 
for those who are pre-registered.
    Meeting schedule subject to change.
    Information about the IACC is available on the Web site: https://www.iacc.hhs.gov.

    Dated: May 30, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-13026 Filed 6-4-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.